Skip to content
HowShorted

CORCEPT THERAPEUTICS INC short interest in 2020

In 2020, CORCEPT THERAPEUTICS INC's disclosed short interest ran from 19.85% of shares outstanding on 15 Jan 2020 to 10.24% on 31 Dec 2020, a change of -9.61 percentage points. The year's high was 20.05% on 31 Jan 2020 and its low 10.24% on 31 Dec 2020, averaging 17.52% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.82 days on 31 Jan 2020. Full history: CORCEPT THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CORCEPT THERAPEUTICS INC in 2020

2020 in figures

Start of year
19.85% (15 Jan 2020)
End of year
10.24% (31 Dec 2020)
Change
-9.61 pp
High
20.05% (31 Jan 2020)
Low
10.24% (31 Dec 2020)
Average
17.52%
Highest days to cover
37.82 (31 Jan 2020)
SEC filings marked
9

Every report in 2020

CORCEPT THERAPEUTICS INC short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202019.85%36.77
31 Jan 202020.05%37.82results (8-K)
14 Feb 202018.68%22.77
28 Feb 202018.74%19.33results (8-K), 10-K filed
13 Mar 202019.27%16.61
31 Mar 202018.18%13.64
15 Apr 202019.18%26.10
30 Apr 202019.12%36.56
15 May 202019.28%25.2210-Q filed, results (8-K)
29 May 202019.22%22.27
15 Jun 202019.40%21.81
30 Jun 202019.77%19.71
15 Jul 202019.53%29.22
31 Jul 202019.12%34.68
14 Aug 202019.49%17.0510-Q filed, results (8-K)
31 Aug 202020.04%30.09
15 Sep 202016.32%1.49
30 Sep 202016.47%14.42
15 Oct 202016.25%33.61
30 Oct 202015.09%27.11
13 Nov 202014.24%17.8310-Q filed, results (8-K)
30 Nov 202011.81%8.05
15 Dec 202011.09%18.03
31 Dec 202010.24%18.76

See also: CORCEPT THERAPEUTICS INC's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.